Labial herpes in dental practice


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The article describes the etiology, stages, and manifestations of labial herpes. The data on the vital activity of the herpes simplex virus type 1, its interaction with the carrier’s organism, and manifestations in the oral cavity both during primary infection and recurrent infection are presented. Risk factors for a doctor and a patient of herpetic orolabial disease during dental treatment and general risk factors for herpes simplex virus type 1 reactivation from a latent state are presented. The modern methods of diagnostics and therapy of labial herpes are indicated. The data presented demonstrate the high potential for the spread of the virus in the body, the successful fight against which is determined mainly by the level of immune defense - both the local barrier, the area of the virus invasion zones, and systemic lymphocytic immunity. Modern methods of therapy contribute to a faster recovery with labial herpes, but at the moment, there are no effective specific means of preventing its recurrence.

Full Text

Restricted Access

About the authors

O. V Grishin

12th Consultative and Diagnostic Center of the Ministry of Defense of the Russian Federation

Email: ov.grishman@mail.ru
Moscow, Russia

A. Yu Shishelova

The N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation; The Institute of Higher Nervous Activity and Neurophysiology of RAS

Email: ihna_ann@mail.ru
Moscow, Russia

References

  1. Дюдюн А. Д., Полион Н. Н., Нагорный А.Е. Герпесвирусная инфекция. Клинико-иммунологические особенности. Клиническая лекция // Дерматовенерология. Косметология. Сексопатология. - 2015. - № 3-4. - С. 119 - 142.
  2. Aslanova M., Ali R., Zito P.M. Herpetic Gingivostomatitis // StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. - 2020. - PMID: 30252324 Free Books & Documents. Review.
  3. Banerjee A., Kulkarni S., Mukherjee A. Herpes Simplex Virus: The Hostile Guest That Takes Over Your Home // Front. Microbiol. - 2020. - Vol. 11. - Art. 733. - P. 1-18.
  4. Bello-Morales R., Ripa I., Lуpez-Guerrero J.A. Extracellular Vesicles in Viral Spread and Antiviral Response // Viruses. - 2020. - Vol. 12, N 6. - Art. 623. - P. 1-20.
  5. Birek C., Ficarra G. The diagnosis and management of oral herpes simplex infection // Curr. Infect. Dis. Rep. - 2006. - Vol. 8, N 3. - P. 181-188.
  6. Bloom D.C., Giordani N.V., Kwiatkowski D.L. Epigenetic regulation of latent HSV-1 gene expression // Biochim. Biophys. Acta. - 2010. - Vol. 1799, N 3-4. - P. 246-256.
  7. Boes H., Goulioumis V., Wechsler A. et al. Clinical Study on the Effectiveness of Three Products in the Treatment of Herpes Simplex Labialis // Sci. Rep. - 2020. - Vol. 10. - Art. 6465. - P. 1-9.
  8. Browning W.D., McCarthy J.P. A Case Series: Herpes Simplex Virus as an Occupational Hazard // J. Esthet. Restor. Dent. - 2012. - Vol. 24, N 1 - P. 61-66.
  9. Chentoufi A. A., BenMohamed L. Mucosal Herpes Immunity and Immunopathology to Ocular and Genital Herpes Simplex Virus Infections // Clin. Dev. Immunol. - 2012. - Vol. 2012. - Art. 149135. - P. 1-22.
  10. Chi C.C., Wang S.H., Delamere F.M. et al. Interventions for prevention of herpes simplex labialis (cold sores on the lips) // Cochrane Database Syst. Rev. - 2015. - Iss. 8. - Art. CD010095. - P. 1-126.
  11. Cunningham A., Griffiths P., Leone P. et al. Current management and recommendations for access to antiviral therapy of herpes labialis // J. Clin. Virol. - 2012. - Vol. 53, N 1. - P. 6-11.
  12. Filho J.S.M., Gobara J.Jr., da Silva Salomao G.V. et al. Cytokine Levels and Human Herpesviruses in Saliva from Clinical Periodontal Healthy Subjects with Peri-Implantitis: A Case-Control Study // Mediators Inflamm. - 2018. - Vol. 2018. - Art. 6020625. - P. 1-7.
  13. Hayderi L.E., Raty L., Failla V. et al. Severe herpes simplex virus type-I infections after dental procedures // Med. Oral Patol. Oral Cir. Bucal. - 2011. - Vol. 16, N 1 - P. e15-е18.
  14. Ivanovska-Stojanoska M., Popovska M., Anastasovska V. et al. Detection of Virus Herpes Simplex Type 1 in Patients with Chronic Periodontal Disease // Open Access Maced. J. Med. Sci. - 2018. - Vol. 6, N 9. - P. 1737-1741.
  15. James C., Harfouche M., Welton N.J. et al. Herpes simplex virus: global infection prevalence and incidence estimates, 2016 // Bull. World Health Organ. - 2020. - Vol. 98, N 5. - P. 315-329.
  16. Kramer T., Enquist L. W. Directional Spread of Alphaherpesviruses in the Nervous System // Viruses. - 2013. - Vol. 5. - P. 678-707.
  17. Kriesel J. D., Jones B. B., Matsunami N. et al. C21orf91 genotypes correlate with herpes simplex labialis (cold sore) frequency: description of a cold sore susceptibility gene // J. Infect. Dis. - 2011. - Vol. 204, N 11. - P. 1654-1662.
  18. Labetoulle M., Maillet S., Efstathiou S. et al. HSV1 latency sites after inoculation in the lip: assessment of their localization and connections to the eye // Invest. Ophthalmol. Vis. Sci. - 2003. - Vol. 44, N 1. - P. 217-225.
  19. La Selva A., Negreiros R.M., Bezerra D.T. et al. Treatment of herpes labialis by photodynamic therapy: study protocol clinical trial (SPIRIT compliant) // Medicine (Baltimore). - 2020. - Vol. 99, N12. - Art. e19500. - P. 1-9.
  20. Lewis M.A. Herpes simplex virus: an occupational hazard in dentistry // Int. Dent. J. - 2004. - Vol. 54, N 2. - P. 103-111.
  21. Mohan R.P.S., Verma S., Singh U., Agarwal N. Acute primary herpetic gingivostomatitis // BMJ Case Rep. - 2013. - Vol. 2013. - Art. bcr2013200074. - P. 1-3.
  22. Opstelten W., Neven A. K., Eekhof J. Treatment and prevention of herpes labialis // Canad. Fam. Physician. - 2008. - Vol. 54, N 12. - P. 1683-1687.
  23. Richter E.R., Dias J.K., Gilbert J.E., Atherton S.S. Distribution of HSV-1 and VZV in Ganglia of the Human Head and Neck // J. Infect. Dis. - 2009. - Vol. 200, N 12. - P. 1901-1906.
  24. Semprini A., Singer J., Braithwaite I. et al. Kanuka honey versus aciclovir for the topical treatment of herpes simplex labialis: a randomised controlled trial // BMJ Open. - 2019. - Vol. 9, N 5. - Art. e026201. - P. 1-9.
  25. Singh A., Preiksaitis J., Romanowski B. The laboratory diagnosis of herpes simplex virus infections // Can. J. Infect. Dis. Med. Microbiol. - 2005. - Vol. 16, N 2. - P. 92-98.
  26. Strasfeld L., Chou S. Antiviral Drug Resistance: Mechanisms and Clinical Implications // Infect. Dis. Clin. North. Am. - 2010. - Vol. 24, N 2. - P. 413-437.
  27. Their K., Petermann P., Rahn E. et al. Mechanical Barriers Restrict Invasion of Herpes Simplex Virus 1 into Human Oral Mucosa // Journal of Virology. - 2017. - Vol. 91, Iss. 22. - Art. e01295-17. - P. 1-13.
  28. Vere Hodge R.A., Field H.J. Antiviral agents for herpes simplex virus // Adv. Pharmacol. - 2013. - Vol. 67. - P. 1-38.
  29. Woolhouse M., Scott F., Hudson Z. et al. Human viruses: discovery and emergence // Philos. Trans. R. Soc. Lond. В. Biol. Sci. - 2012. - Vol. 367, N 1604. - P. 2864-2871.
  30. Zaichick S.V., Bohannon K.P., Smith G.A. Alphaherpesviruses and the cytoskeleton in neuronal infections // Viruses. - 2011. - Vol. 3, N 7. - P. 941-981.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2021 Grishin O.V., Shishelova A.Y.


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: № 01975 от 30.12.1992.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies